Cite Filings / ALLO / 0001628280-26-028953

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Allogene Therapeutics, Inc. Filed 2026-04-30 Acc 0001628280-26-028953

Documents 1

DEFA14A Proxy Materials , allo-20260430xdefa14axnoti.htm

Around this filing

2026-05-21 DEFA14A Proxy Materials
2026-04-30 ARS Annual Report to Security Holders
2026-04-30 DEFA14A Proxy Materials
2026-04-30 DEF 14A Proxy Statement
2026-04-23 4 SVP, Finance sold 9,586 shares at $2.31 ($22,144)
2026-04-23 SCHEDULE 13G Statement of Beneficial Ownership
2025-04-30 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading allo-20260430xdefa14axnoti.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…